from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1438/tpi

LFCtreatmentdescriptionclass of inhibitor

-1.512

Amikacinug/mL Amikacintranslation

-2.634

Cap5-10ug/mL Capreomycintranslation

-2.923

Rox10-50 ug/mL Roxithromycintranslation

0.029

SM2-5 ug/mL Streptomycintranslation

-2.537

Tet5-10 ug/mL Tetracyclinetranslation

0.780

Rif0.2-5ug/mL Rifampicintranscription

-0.298

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.133

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.716

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.485

CPZ10-50 ug/mL Chlorpromazinerespiration

0.017

Clofazimine10-13 ug/mL Clofaziminerespiration

0.632

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.390

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.193

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.058

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.262

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.462

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.286

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.521

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.251

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.583

KCN5-20 ug/mL Potassium cyaniderespiration

0.493

NaN30.2-2 mM Sodium aziderespiration

0.393

Nigericin50 uM Nigericinrespiration

-0.107

TRC10-150 ug/mL Triclosanrespiration

-1.623

TRZ10-25 ug/mL Thioridazinerespiration

-2.389

Valinomycin0.5-10 uM Valinomycinrespiration

0.878

ZnSO42 mM ZnSO4respiration

0.228

menadione6-10 ug/mL Menadionerespiration

-0.498

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.413

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.131

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.555

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.871

NRP_1Non-replicating persistence stage 1dosRassociated

0.747

Amp0.2mg/mL AmpicillincellWall

0.265

Cephalexin20-100 ug/mL CephalexincellWall

0.384

Cerulenin0.32-5 ug/mL CerulenincellWall

0.553

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.810

EMB10-20 ug/mL EthambutolcellWall

0.404

Eta12-40 ug/mL EthionamidecellWall

0.331

INH0.2-0.4 ug/mL IsoniazidcellWall

0.582

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.588

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.835

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.618

BZA0.12 mg/mL BenzamidearomaticAmides

0.591

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.328

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.319

H2O24 mM hydrogen peroxideDNAdamaging

-0.629

Levo10 ug/mL LevofloxacinDNAdamaging

0.759

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.788

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.559

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.332

UVUV-irradiationDNAdamaging

-1.068

ARP41-4 ug/mL Antitubercular compound ARP4?

0.213

Antimycin12.5-50 ug/mL Antimycin A?

0.806

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.332

PA_110-50 ug/mL Antitubercular compound PA-1?

0.244

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.257

PA8240.2-2 ug/mL PA-824?

-0.146

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.410

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.402

Verapamil50 uM Verapamil?

0.466

mercaptoethanol2 mM 2-Mercaptoethanol?

0.366

methoxatin10-20 ug/mL Methoxatin?